yeztugo lenacapavir - Search News

News

HIV prevention drug lenacapavir approved by FDA

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

Wired · 23h

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

STAT · 2d

HIV protection with just two shots a year: FDA approves Gilead drug

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the current political climate.

1hon MSN

Here’s what everyone should know about this new HIV prevention shot

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

MPR19h

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...

23h

FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag

Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...

USFDA Okays Lenacapavir: Affordable, Generic India-Made Drug Key To Boost Global HIV Prevention

While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...

Managed Healthcare Executive2d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results